HLA-Haploidentical Transplantation in Children with Primary Immunodeficiency Using Post Cyclophosphamide

被引：0

作者：

Alsaedi, Hawazen Saleh ^{[1
]}

Mohammed, Reem ^{[2
]}

Ayas, Mouhab ^{[3
]}

Siddiqui, Khawar ^{[4
]}

Ghemlas, Ibrahim ^{[5
]}

AlMusa, Hamoud ^{[2
]}

AlSaud, Bandar ^{[2
]}

Arnaout, Rand ^{[6
]}

AlDhekri, Hasan ^{[2
]}

Jafri, Rafat ^{[7
]}

Alahmari, Ali ^{[7
]}

AlJefri, Abdullah ^{[8
]}

Alseraihy, Amal ^{[9
]}

机构：

[1] King Faisal Specialist Hosp & Res Ctr, Pediat Hematol Oncol Dept, Riyadh, Saudi Arabia

[2] King Faisal Specialist Hosp & Res Ctr, Pediat Dept, Riyadh, Saudi Arabia

[3] King Faisal Specialist Hosp & Res Ctr, Pediat Hematol Oncol Dept, Riyadh, Saudi Arabia

[4] King Faisal Specialist Hosp & Res Ctr, Dept Pediat Hematol Oncol, Riyadh, Saudi Arabia

[5] King Faisal Specialist Hosp & Res Ctr, Pediat Hematol Oncol Dept, Riyadh, Saudi Arabia

[6] King Faisal Specialist Hosp & Res Ctr, Med Dept, Riyadh, Saudi Arabia

[7] KFSH&RC, Riyadh, Saudi Arabia

[8] King Faisal Specialist Hosp & Res Ctr, Pediat Hematol Oncol, Riyadh, Saudi Arabia

[9] King Faisal Specialist Hosp & Res Ctr, Pediat Hematol Oncol Dept, Riyadh, Saudi Arabia

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2020年 / 26卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

320

引用

页码：S216 / S216

页数：1

共 50 条

[31] Single Cord Blood Transplantation Versus HLA-Haploidentical Related Donor Transplantation Using Post-Transplant Cyclophosphamide in Patients with Hematological Malignancies
Wada, Fumiya
Kanda, Junya
Yoshioka, Satoshi
Ishikawa, Takayuki
Akasaka, Takashi
Ueda, Yasunori
Hirata, Hirokazu
Arai, Yasuyuki
Yago, Kazuhiro
Anzai, Naoyuki
Watanabe, Mitsumasa
Ikeda, Takashi
Yonezawa, Akihito
Imada, Kazunori
Itoh, Mitsuru
Kitano, Toshiyuki
Takeoka, Tomoharu
Hishizawa, Masakatsu
Nohgawa, Masaharu
Arima, Nobuyoshi
Asagoe, Kosuke
Kondo, Tadakazu
Takaori-Kondo, Akifumi
BLOOD, 2021, 138
[32] IMPACT OF HLA DISPARITY ON OUTCOME IN HLA-HAPLOIDENTICAL BONE MARROW TRANSPLANTATION FOLLOWED BY HIGH DOSE POST-TRANSPLANT CYCLOPHOSPHAMIDE
Giannoni, L.
Raiola, A. M.
Sacchi, N.
Garbarino, L.
Dominietto, A.
Varaldo, R.
Bregante, S.
Di Grazia, C.
Aquino, S.
Ibatici, A.
Gualandi, F.
Van Lint, M. T.
Lamparelli, T.
Risitano, A.
Bacigalupo, A.
Angelucci, E.
HAEMATOLOGICA, 2017, 102 : 325 - 326
[33] HLA-HAPLOIDENTICAL BONE-MARROW TRANSPLANTATION IN INFANTS WITH SEVERE COMBINED IMMUNODEFICIENCY
FRIEDRICH, W
BLUTTERS, R
GOLDMANN, SF
RAGHAVACHAR, A
KLEIHAUER, E
IMMUNOBIOLOGY, 1984, 168 (1-2) : 41 - 41
[34] Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults
Kasamon, Yvette L.
Bolanos-Meade, Javier
Prince, Gabrielle T.
Tsai, Hua-Ling
McCurdy, Shannon R.
Kanakry, Jennifer A.
Rosner, Gary L.
Brodsky, Robert A.
Perica, Karlo
Smith, B. Douglas
Gladstone, Douglas E.
Swinnen, Lode J.
Showel, Margaret M.
Matsui, William H.
Huff, Carol Ann
Borrello, Ivan
Pratz, Keith W.
McDevitt, Michael A.
Gojo, Ivana
Dezern, Amy E.
Shanbhag, Satish
Levis, Mark J.
Luznik, Leo
Ambinder, Richard F.
Fuchs, Ephraim J.
Jones, Richard J.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28) : 3152 - +
[35] Post-Transplantation Cyclophosphamide and Short-Term Methotrexate for Tolerance Induction in HLA-Haploidentical Transplantation for Severe Aplastic Anemia
Fu, Bin
Xu, Yajing
Chen, Yan
Chen, Fangping
BLOOD, 2017, 130
[36] Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease
Wiebking, Volker
Hutker, Sebastian
Schmid, Irene
Immler, Stefanie
Feuchtinger, Tobias
Albert, Michael H.
ANNALS OF HEMATOLOGY, 2017, 96 (08) : 1373 - 1377
[37] Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease
Volker Wiebking
Sebastian Hütker
Irene Schmid
Stefanie Immler
Tobias Feuchtinger
Michael H. Albert
Annals of Hematology, 2017, 96 : 1373 - 1377
[38] HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus HLA-Matched Unrelated Donor Transplantation for Myelodysplastic Syndrome
Nakaya, Yosuke
Koh, Hideo
Konuma, Takaaki
Shimomura, Yoshimitsu
Ishiyama, Ken
Itonaga, Hidehiro
Hino, Masayuki
Doki, Noriko
Nishida, Tetsuya
Ohigashi, Hiroyuki
Matsuoka, Ken-ichi
Kanda, Yoshinobu
Maruyama, Yumiko
Sawa, Masashi
Eto, Tetsuya
Hiramoto, Nobuhiro
Fukuda, Takahiro
Atsuta, Yoshiko
Nakamae, Hirohisa
TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (03): : 316.e1 - 316.e12
[39] Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide
Junichi Sugita
Yusuke Kagaya
Toshihiro Miyamoto
Yasuhiko Shibasaki
Koji Nagafuji
Shuichi Ota
Tatsuo Furukawa
Miho Nara
Koichi Akashi
Shuichi Taniguchi
Mine Harada
Keitaro Matsuo
Takanori Teshima
Bone Marrow Transplantation, 2019, 54 : 432 - 441
[40] Reduced dose of posttransplant cyclophosphamide in HLA-haploidentical peripheral blood stem cell transplantation
Junichi Sugita
Tomohiko Kamimura
Takayuki Ishikawa
Shuichi Ota
Tetsuya Eto
Takashi Kuroha
Yasuhiko Miyazaki
Hiroaki Kumagai
Keitaro Matsuo
Koichi Akashi
Shuichi Taniguchi
Mine Harada
Takanori Teshima
Bone Marrow Transplantation, 2021, 56 : 596 - 604

← 1 2 3 4 5 →